NCC Medical Group is a leading manufacturer of neuro-diagnostic and neuro-monitoring solutions dedicated to advancing modern neurological healthcare. Established in 1997, the company has built a strong reputation for delivering reliable medical technologies that support accurate diagnosis, safer surgeries, and improved patient outcomes.
Recognized as a National “Little Giant” SRDI Enterprise, NCC focuses on specialized, refined, differential, and innovative technologies. This prestigious designation is awarded to companies that demonstrate outstanding technological innovation and possess proprietary intellectual property within their industries.
The core research and manufacturing operations of NCC are located in Shanghai, China. This advanced facility integrates neuroscience research, electronic engineering, and precision manufacturing processes to develop high-performance neurodiagnostic equipment. From amplifier design to electrode integration, every EEG Recording System is manufactured using strict quality control procedures to ensure signal accuracy, hardware stability, and long-term durability.
Each production stage—including circuit assembly, system calibration, and functional validation—is conducted under internationally recognized quality management standards. These processes ensure that NCC products consistently meet the performance expectations of hospitals, research institutes, and global distributors.
To support global distribution, NCC maintains a quality and regulatory management center in Singapore. This hub ensures compliance with international medical standards, including ISO certification and regional regulatory requirements. Through rigorous testing and certification procedures, every EEG Recording System is validated for clinical safety, electromagnetic compatibility, and signal integrity.
This global quality strategy enables NCC to supply neurodiagnostic equipment to hospitals and research institutions across multiple continents while maintaining consistent performance and regulatory compliance.
NCC has established 31 training and technical support centers across China and continues to expand its international service infrastructure. Through the NeuGuard Service Platform, healthcare institutions receive remote technical support, system diagnostics, and maintenance guidance. This platform ensures that hospitals and research laboratories can maintain optimal performance of their EEG Recording System installations.
Additionally, the NCC Innovation Academy provides continuous professional education programs for clinicians, biomedical engineers, and researchers. Training programs include EEG technology applications, intraoperative neuromonitoring procedures, and advanced neurophysiology analysis techniques.
Today, NCC neurodiagnostic technologies are deployed in more than 50 countries and over 5,000 hospitals throughout China. The company collaborates with top-tier teaching hospitals, regional medical centers, and neuroscience laboratories worldwide.
Through a growing global distributor network, NCC continues to expand its international presence, delivering reliable EEG Recording System solutions to healthcare providers across Southeast Asia, Europe, Australia, the Americas, and Africa.
NCC Medical Group is committed to safeguarding life and health by providing advanced neurodiagnostic technologies that enable safer surgeries, precise neurological diagnostics, and improved patient care.
Copyright © NCC Medical Co., Ltd. - Privacy policy